State Street’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255M Buy
5,896,596
+146,977
+3% +$6.35M 0.01% 775
2025
Q1
$199M Sell
5,749,619
-433,008
-7% -$15M 0.01% 895
2024
Q4
$170M Buy
6,182,627
+219,973
+4% +$6.04M 0.01% 1036
2024
Q3
$152M Buy
5,962,654
+108,514
+2% +$2.76M 0.01% 1088
2024
Q2
$148M Buy
5,854,140
+461,278
+9% +$11.7M 0.01% 1043
2024
Q1
$167M Buy
5,392,862
+305,963
+6% +$9.46M 0.01% 979
2023
Q4
$205M Buy
5,086,899
+46,485
+0.9% +$1.88M 0.01% 826
2023
Q3
$133M Sell
5,040,414
-2,028,946
-29% -$53.5M 0.01% 997
2023
Q2
$122M Buy
7,069,360
+1,926,347
+37% +$33.1M 0.01% 1091
2023
Q1
$85.3M Sell
5,143,013
-3,701,930
-42% -$61.4M ﹤0.01% 1294
2022
Q4
$67.4M Buy
8,844,943
+902,132
+11% +$6.87M ﹤0.01% 1430
2022
Q3
$79M Sell
7,942,811
-3,014,252
-28% -$30M 0.01% 1276
2022
Q2
$99.5M Buy
10,957,063
+1,750,829
+19% +$15.9M 0.01% 1150
2022
Q1
$93.4M Buy
9,206,234
+5,683,771
+161% +$57.7M ﹤0.01% 1339
2021
Q4
$58.8M Buy
3,522,463
+438,604
+14% +$7.32M ﹤0.01% 1701
2021
Q3
$145M Buy
3,083,859
+430,363
+16% +$20.2M 0.01% 1014
2021
Q2
$162M Buy
2,653,496
+288,124
+12% +$17.6M 0.01% 970
2021
Q1
$146M Buy
2,365,372
+68,849
+3% +$4.24M 0.01% 964
2020
Q4
$163M Sell
2,296,523
-57,985
-2% -$4.12M 0.01% 835
2020
Q3
$88.3M Sell
2,354,508
-831,813
-26% -$31.2M 0.01% 1047
2020
Q2
$104M Buy
3,186,321
+1,472,605
+86% +$48M 0.01% 931
2020
Q1
$49.7M Buy
1,713,716
+905,473
+112% +$26.3M ﹤0.01% 1253
2019
Q4
$28.3M Buy
808,243
+456,605
+130% +$16M ﹤0.01% 1897
2019
Q3
$7.55M Buy
+351,638
New +$7.55M ﹤0.01% 2598